Belpointe Asset Management LLC Acquires 38 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Belpointe Asset Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,799 shares of the healthcare conglomerate’s stock after buying an additional 38 shares during the period. Belpointe Asset Management LLC’s holdings in UnitedHealth Group were worth $4,451,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the stock. Hanlon Investment Management Inc. lifted its position in UnitedHealth Group by 15.2% in the 4th quarter. Hanlon Investment Management Inc. now owns 682 shares of the healthcare conglomerate’s stock valued at $345,000 after acquiring an additional 90 shares in the last quarter. CreativeOne Wealth LLC lifted its holdings in shares of UnitedHealth Group by 11.3% during the fourth quarter. CreativeOne Wealth LLC now owns 13,248 shares of the healthcare conglomerate’s stock valued at $6,702,000 after purchasing an additional 1,345 shares in the last quarter. Mariner LLC raised its position in UnitedHealth Group by 1.3% in the 4th quarter. Mariner LLC now owns 506,132 shares of the healthcare conglomerate’s stock worth $256,040,000 after buying an additional 6,588 shares during the last quarter. Cohen & Steers Inc. lifted its stake in UnitedHealth Group by 36.1% during the 4th quarter. Cohen & Steers Inc. now owns 656 shares of the healthcare conglomerate’s stock valued at $332,000 after acquiring an additional 174 shares during the period. Finally, Peninsula Wealth LLC raised its holdings in shares of UnitedHealth Group by 4.9% during the fourth quarter. Peninsula Wealth LLC now owns 647 shares of the healthcare conglomerate’s stock valued at $327,000 after purchasing an additional 30 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Truist Financial boosted their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the company a “buy” rating in a research note on Friday. Wells Fargo & Company dropped their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Twenty-one research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $632.85.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Up 0.8 %

UnitedHealth Group stock opened at $599.10 on Monday. The stock has a market cap of $548.00 billion, a PE ratio of 38.65, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $438.50 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a 50-day moving average of $512.87 and a two-hundred day moving average of $541.80.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.40%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.